A new study of mice lacking one copy of the gene Scn2a is offering a detailed molecular view of how a single genetic disruption can reshape the developing brain. Using single-nucleus transcriptomics, researchers examined the prefrontal cortex—a region central to decision-making, attention, working memory, social behavior and emotional regulation—and identified widespread changes in the activity of genes across individual brain cells. The findings add fresh evidence that neurodevelopmental disorders linked to SCN2A mutations may arise from complex, cell-specific disturbances rather than from a single faulty biological pathway.
Published in Translational Psychiatry, the study by Yoo, Zhang, Mandal and colleagues focuses on Scn2a-deficient mice. The human SCN2A gene encodes NaV1.2, a voltage-gated sodium channel concentrated at neuronal membranes. These channels help nerve cells generate and transmit electrical impulses, allowing information to travel through neural circuits. Variants that impair SCN2A function have been associated with developmental delay, intellectual disability and autism-related traits, while other variants can increase neuronal excitability and contribute to epilepsy. The gene therefore sits at a critical junction between electrical signaling and brain development.
To investigate the consequences of Scn2a deficiency, the researchers used single-nucleus RNA sequencing, a method that profiles gene activity in individual cell nuclei. Instead of measuring an average signal from an entire piece of brain tissue, the technique separates molecular information from thousands of nuclei and assigns each nucleus to a particular cell type or cellular state. This distinction is crucial in the brain, where neurons, astrocytes, oligodendrocytes, microglia and other cells perform different functions and may respond differently to the same genetic change.
The resulting molecular map revealed disrupted transcriptional programs in the prefrontal cortex. Transcriptional programs are coordinated sets of genes that become active together to support processes such as synaptic communication, energy production, structural maintenance and immune signaling. When these programs are altered, the effect can extend far beyond the protein directly encoded by the mutated gene. In Scn2a-deficient animals, the study indicates that loss of normal sodium-channel function is associated with broader changes in the molecular machinery that sustains neural circuits.
One important implication is that the impact of Scn2a deficiency may not be confined to the electrical properties of neurons. Neurons rely on precisely regulated gene networks to build synapses, transport materials along their processes, respond to incoming signals and maintain stable levels of excitation. Disruption in these systems can weaken communication between cells or disturb the balance between excitation and inhibition. That balance is essential: excessive excitation can destabilize circuits, while insufficient activity can interfere with learning, development and adaptive behavior.
The single-nucleus approach also allows researchers to distinguish changes that occur in specific populations of cells. A gene-expression shift in excitatory neurons may have a different meaning from a similar shift in inhibitory interneurons or glial cells. Glial cells, once regarded mainly as support cells, regulate neurotransmitter levels, provide metabolic assistance, shape synapses and participate in inflammatory responses. By examining these populations separately, the study provides a more refined picture of how Scn2a deficiency may alter communication among the diverse cellular communities that make up the prefrontal cortex.
The prefrontal cortex is especially relevant to conditions associated with SCN2A mutations because it develops over an extended period and depends on carefully timed interactions between neurons and supporting cells. Its circuits integrate sensory information, regulate behavior and coordinate responses to changing circumstances. Molecular disturbances in this region could therefore have consequences that emerge across multiple domains, including cognition, social interaction and behavioral flexibility. The mouse findings do not directly reproduce human disease, but they identify biological processes that can now be tested in additional models and patient-derived cells.
By revealing disrupted pathways rather than focusing only on one gene, the research may also help explain why SCN2A-related disorders show such diverse clinical features. The same gene can contribute to very different outcomes depending on the exact mutation, developmental stage, cell type affected and surrounding genetic environment. A pathway-level view could help scientists determine which molecular changes are shared across patients and which are specific to particular forms of SCN2A dysfunction. In the longer term, that information could support more precisely targeted treatments.
The study does not mean that a single molecular signature can predict behavior or provide an immediate therapy. Further work will be needed to confirm which transcriptional changes directly alter neural function, determine when they arise, and establish whether they can be reversed. Nevertheless, the findings demonstrate the power of single-nucleus transcriptomics to expose hidden cellular effects of gene loss. As researchers continue mapping the brain one cell at a time, studies such as this are transforming genetic clues into mechanistic explanations for neurodevelopmental disorders—and bringing scientists closer to interventions designed around the biology of individual circuits.
Subject of Research: Scn2a deficiency and disrupted molecular pathways in the prefrontal cortex of mice
Article Title: Single-nucleus transcriptomics reveals disrupted pathways in the prefrontal cortex of Scn2a-deficient mice
Article References: Yoo, YE., Zhang, Z., Mandal, P. et al. “Single-nucleus transcriptomics reveals disrupted pathways in the prefrontal cortex of Scn2a-deficient mice.” Translational Psychiatry (2026). https://doi.org/10.1038/s41398-026-04348-0
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41398-026-04348-0
Keywords: SCN2A, Scn2a deficiency, single-nucleus transcriptomics, prefrontal cortex, neurodevelopmental disorders, autism, epilepsy, gene expression, neuronal circuits, mouse model
